2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2275

The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups
Abstract Number: 1283

The Burden of Non-Radiographic Axial Spondyloarthritis from the Employer Perspective: A Real World European Study
Abstract Number: 3019

The CD4+CD52low T Cell Contributes to Disease Activity and Autoantybody Production in Systemic Lupus Erythematosus
Abstract Number: 1531

The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years
Abstract Number: 1199

The Charla De Lupus (Lupus Chat)® Program: An Evaluation of a Lupus Support Program for Teens, Young Adults and Parents
Abstract Number: 3183

The Clinical and Economic Costs of Not Achieving Remission in Rheumatoid Arthritis
Abstract Number: 355

The Clinical and Genetic Spectrum of Low Alkaline Phosphatase in Adults
Abstract Number: 1216

The Clinical and Ultrasonographic Presentation of Seronegative RA Is More Severe Compared to Seropositive RA in an Inception Cohort of DMARD-Naïve Patients Classified According to the 2010 ACR/EULAR Criteria
Abstract Number: 3203

The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, in Primary Sjögren’s Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial
Abstract Number: 2371

The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti- Melanoma Differentiation-Associated Gene 5 Antibody
Abstract Number: 1535

The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
Abstract Number: 2384

The Comparative Efficacy of Dry Needling, Kinesio Taping and Physical Therapy in Patients with Myofascial Pain Syndrome
Abstract Number: 3232

The Comparative Efficacy of Kinesio Taping and Local Steroid Injection in Patients with Subacromial Impingement Syndrome
Abstract Number: 2328

The Correlation of Childhood Health Assessment Questionnaire with Disease Activity in Juvenile Idiopathic Arthritis
Abstract Number: 1183

The Country Where You Perform Your Rheumatology Training Is Associated with the Acquired Confidence, the Education Received and the Assessment in Core Competences

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].